NCT00320229

Brief Summary

The aim of our study was to demonstrate that, during a percutaneous coronary intervention, even smaller amounts of abciximab than standard dose, injected locally, could achieve a rapid thrombus resolution and clinical improvement without concomitant differences in hemorrhagic complications

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Dec 2004

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2004

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2005

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2006

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 3, 2006

Completed
Last Updated

May 16, 2006

Status Verified

January 1, 2006

First QC Date

April 18, 2006

Last Update Submit

May 15, 2006

Conditions

Coronary DiseaseMyocardial Infarction

Keywords

angioplastystentabciximabPlatelet Glycoprotein GPIIb-IIIa Complexmyocardial infarction

Interventions

abciximabDRUG

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • presenting with unstable angina
  • presenting with acute myocardial infarction
  • eligibility for percutaneous coronary intervention

You may not qualify if:

  • presenting with cardiogenic shock

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiologia 2 - Emodinamica - Ospedale Maggiore

Novara, 28100, Italy

Location

MeSH Terms

Conditions

Coronary DiseaseMyocardial Infarction

Interventions

Abciximab

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

Immunoglobulin Fab FragmentsImmunoglobulin FragmentsPeptide FragmentsPeptidesAmino Acids, Peptides, and ProteinsAntibodies, Monoclonal, HumanizedAntibodies, MonoclonalAntibodiesImmunoglobulinsImmunoproteinsBlood ProteinsProteinsSerum GlobulinsGlobulins

Study Officials

  • Mara Sansa

    Chief Interventional Cardiology - Ospedale Maggiore - Novara - Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 18, 2006

First Posted

May 3, 2006

Study Start

December 1, 2004

Study Completion

July 1, 2005

Last Updated

May 16, 2006

Record last verified: 2006-01

Locations

IT(1)